{"id":4486,"date":"2024-09-27T04:30:28","date_gmt":"2024-09-26T19:30:28","guid":{"rendered":"https:\/\/stevenbleistein.net\/?p=4486"},"modified":"2024-09-28T08:43:08","modified_gmt":"2024-09-27T23:43:08","slug":"takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang","status":"publish","type":"post","link":"https:\/\/stevenbleistein.net\/ja\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/","title":{"rendered":"\u300cCONVERSATION WITH \u30ad\u30e3\u30b9\u30d1\u30fc \u30d6\u30c3\u30ab \u30de\u30a4\u30eb\u30f4\u30a1\u30f3\u6c0f\uff08\u30ce\u30dc \u30ce\u30eb\u30c7\u30a3\u30b9\u30af \u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e \u4ee3\u8868\u53d6\u7de0\u5f79\u793e\u9577\uff09\u300d\u304b\u3089\u5b66\u3093\u3060\u3053\u3068"},"content":{"rendered":"<p>9\u670825\u65e5\u3001\u79c1\u306f\u5728\u65e5\u30d5\u30e9\u30f3\u30b9\u5546\u5de5\u4f1a\u8b70\u6240\u306b\u3066\u3001\u30ce\u30dc\u30ce\u30eb\u30c7\u30a3\u30b9\u30af\u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e\u306e\u4ee3\u8868\u53d6\u7de0\u5f79\u793e\u9577\u3067\u3042\u308b\u30ad\u30e3\u30b9\u30d1\u30fc \u30d6\u30c3\u30ab \u30de\u30a4\u30eb\u30f4\u30a1\u30f3\u6c0f\u3068\u306e\u5bfe\u8ac7\u3092\u884c\u3044\u307e\u3057\u305f\u3002\u4ee5\u4e0b\u306f\u3001\u305d\u306e\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u304b\u3089\u306e\u8981\u70b9\u3067\u3059\u3002<!--more--><\/p>\n<ol>\n<li>\u80a5\u6e80\u306f\u6975\u3081\u3066\u6cbb\u7642\u53ef\u80fd\u306a\u75c5\u6c17\u3067\u3042\u308b\u3002\u65e5\u672c\u306e\u533b\u7642\u754c\u3082\u3053\u306e\u8003\u3048\u306b\u5f90\u3005\u306b\u7406\u89e3\u3092\u793a\u3057\u3064\u3064\u3042\u308b\u304c\u3001\u307e\u3060\u5341\u5206\u3067\u306f\u306a\u3044\u3002\u533b\u7642\u5c02\u9580\u5bb6\u3078\u306e\u6559\u80b2\u3092\u7e70\u308a\u8fd4\u3057\u884c\u3046\u3053\u3068\u304c\u512a\u5148\u4e8b\u9805\u3060\u3002<\/li>\n<li>\u3059\u3079\u3066\u306e\u4eba\u304c\u3001\u3042\u3089\u3086\u308b\u75c5\u6c17\u306b\u5bfe\u3057\u3066\u53ef\u80fd\u306a\u9650\u308a\u6700\u5584\u306e\u533b\u7642\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u53d7\u3051\u308b\u6a29\u5229\u3092\u6301\u3063\u3066\u304a\u308a\u3001\u305d\u308c\u306b\u306f\u80a5\u6e80\u3082\u542b\u307e\u308c\u308b\u3002<\/li>\n<li>\u80a5\u6e80\u3068\u306e\u95d8\u3044\u306f\u591a\u304f\u306e\u4eba\u3005\u306b\u3068\u3063\u3066\u533b\u7642\u7684\u306a\u8ab2\u984c\u3067\u3042\u308a\u3001\u5358\u306a\u308b\u610f\u5fd7\u306e\u529b\u306e\u554f\u984c\u3067\u306f\u306a\u3044\u3002\u80a5\u6e80\u306b\u306f\u751f\u7406\u5b66\u3084\u907a\u4f1d\u5b66\u3082\u95a2\u4fc2\u3057\u3066\u304a\u308a\u3001\u7279\u5225\u306a\u30b5\u30dd\u30fc\u30c8\u304c\u5fc5\u8981\u306a\u4eba\u3082\u3044\u308b\u3002<\/li>\n<li>\u65e5\u672c\u306e\u653f\u5e9c\u898f\u5236\u5f53\u5c40\u306b\u3068\u3063\u3066\u65e5\u672c\u56fd\u6c11\u306e\u5065\u5eb7\u7d50\u679c\u3092\u6539\u5584\u3059\u308b\u3053\u3068\u306b\u306f\u5927\u304d\u306a\u5229\u70b9\u304c\u3042\u308a\u3001\u307e\u305f\u5f7c\u3089\u306f\u305d\u308c\u3092\u5b9f\u73fe\u3059\u308b\u305f\u3081\u306e\u5207\u8feb\u611f\u3092\u611f\u3058\u3066\u3044\u308b\u3002\u898f\u5236\u5f53\u5c40\u306b\u5bfe\u3057\u3066\u65e5\u672c\u56fd\u6c11\u306e\u5065\u5eb7\u306e\u5927\u5207\u3055\u3092\u8a34\u3048\u308b\u3053\u3068\u306b\u306f\u3001\u8aac\u5f97\u529b\u304c\u3042\u308a\u3001\u7d0d\u5f97\u3055\u305b\u308b\u529b\u3092\u6301\u3063\u3066\u3044\u308b\u3002<\/li>\n<li>\u80a5\u6e80\u3068\u306e\u95d8\u3044\u306f\u533b\u85ac\u54c1\u3060\u3051\u3067\u306f\u4e0d\u5341\u5206\u3067\u3042\u308a\u3001\u533b\u7642\u3001\u5fc3\u7406\u7642\u6cd5\u3001\u30d5\u30a3\u30c3\u30c8\u30cd\u30b9\u30b3\u30fc\u30c1\u30f3\u30b0\u3001\u98df\u4e8b\u6307\u5c0e\u306a\u3069\u3001\u8907\u6570\u306e\u5206\u91ce\u304c\u95a2\u308f\u308b\u5305\u62ec\u7684\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u304c\u5fc5\u8981\u3002<\/li>\n<li>\u80a5\u6e80\u306b\u95a2\u9023\u3059\u308b\u4f75\u5b58\u75be\u60a3\uff08\u5fc3\u81d3\u75c5\u3001\u9ad8\u8840\u5727\u3001\u7cd6\u5c3f\u75c5\u306a\u3069\uff09\u3084\u3001\u305d\u308c\u3089\u306e\u75c5\u6c17\u306e\u7d4c\u6e08\u7684\u5f71\u97ff\u306b\u3088\u308a\u3001\u80a5\u6e80\u5bfe\u7b56\u306f\u65e5\u672c\u306e\u898f\u5236\u5f53\u5c40\u306b\u3068\u3063\u3066\u516c\u8846\u885b\u751f\u306e\u512a\u5148\u4e8b\u9805\u3068\u306a\u3063\u3066\u3044\u308b\u3002<\/li>\n<li>\u65e5\u672c\u3067\u306f\u3001\u80a5\u6e80\u306f\u72ec\u81ea\u306e\u533b\u7642\u5c02\u9580\u5206\u91ce\u3068\u3057\u3066\u8a8d\u8b58\u3055\u308c\u3066\u304a\u3089\u305a\u3001\u8907\u6570\u306e\u533b\u7642\u5c02\u9580\u5206\u91ce\u304c\u95a2\u4e0e\u3057\u3066\u3044\u308b\u305f\u3081\u3001\u533b\u7642\u5c02\u9580\u5bb6\u306b\u5bfe\u3059\u308b\u80a5\u6e80\u533b\u7642\u306e\u6559\u80b2\u306f\u3001\u7c98\u308a\u5f37\u3055\u3068\u5fcd\u8010\u304c\u5fc5\u8981\u306a\u7279\u5225\u306a\u8ab2\u984c\u3068\u306a\u3063\u3066\u3044\u308b\u3002<\/li>\n<li>\u65e5\u672c\u306e\u7d44\u7e54\u3067\u306f\u3001\u610f\u601d\u6c7a\u5b9a\u304c\u9045\u3044\u3053\u3068\u304c\u3042\u308b\u304c\u3001\u5408\u610f\u304c\u5f97\u3089\u308c\u305f\u5f8c\u306e\u5b9f\u884c\u306f\u8fc5\u901f\u3060\u3002\u4e00\u65b9\u3067\u3001\u30d5\u30e9\u30f3\u30b9\u306e\u7d44\u7e54\u3067\u306f\u610f\u601d\u6c7a\u5b9a\u304c\u65e9\u3044\u3053\u3068\u304c\u591a\u3044\u304c\u3001\u5b9f\u884c\u304c\u9045\u304f\u3001\u4e0d\u5b89\u5b9a\u3001\u6563\u6f2b\u306b\u306a\u308b\u3053\u3068\u304c\u3042\u308a\u3001\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u306e\u4ecb\u5165\u3084\u6307\u5c0e\u304c\u5fc5\u8981\u3002<\/li>\n<li>\u6839\u56de\u3057\u3001\u3064\u307e\u308a\u4f1a\u8b70\u306e\u524d\u306b\u500b\u5225\u306b\u5408\u610f\u3092\u5f62\u6210\u3059\u308b\u3053\u3068\u306f\u65e5\u672c\u3084\u4ed6\u306e\u5730\u57df\u3067\u3082\u4e00\u822c\u7684\u306a\u6163\u884c\u3060\u304c\u3001\u4f1a\u8b70\u5f8c\u306e\u6839\u56de\u3057\u3082\u307e\u305f\u3001\u5168\u54e1\u304c\u5171\u901a\u306e\u7406\u89e3\u3068\u4e00\u8cab\u3057\u305f\u884c\u52d5\u306b\u5411\u304b\u3063\u3066\u9032\u3093\u3067\u3044\u308b\u3053\u3068\u3092\u78ba\u8a8d\u3059\u308b\u305f\u3081\u306b\u8ce2\u660e\u306a\u3082\u306e\u3068\u8a00\u3048\u308b\u3002<\/li>\n<\/ol>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-4488\" src=\"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2024\/09\/KasperBodkerMejlvang-2.jpg\" alt=\"Kasper Bodker Mejivang\" width=\"420\" height=\"560\" srcset=\"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2024\/09\/KasperBodkerMejlvang-2.jpg 420w, https:\/\/stevenbleistein.net\/wp-content\/uploads\/2024\/09\/KasperBodkerMejlvang-2-225x300.jpg 225w, https:\/\/stevenbleistein.net\/wp-content\/uploads\/2024\/09\/KasperBodkerMejlvang-2-9x12.jpg 9w\" sizes=\"(max-width: 420px) 100vw, 420px\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>9\u670825\u65e5\u3001\u79c1\u306f\u5728\u65e5\u30d5\u30e9\u30f3\u30b9\u5546\u5de5\u4f1a\u8b70\u6240\u306b\u3066\u3001\u30ce\u30dc\u30ce\u30eb\u30c7\u30a3\u30b9\u30af\u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e\u306e\u4ee3\u8868\u53d6\u7de0\u5f79\u793e\u9577\u3067\u3042\u308b\u30ad\u30e3\u30b9\u30d1\u30fc \u30d6\u30c3\u30ab \u30de\u30a4\u30eb\u30f4\u30a1\u30f3\u6c0f\u3068\u306e\u5bfe\u8ac7\u3092\u884c\u3044\u307e\u3057\u305f\u3002\u4ee5\u4e0b\u306f\u3001\u305d\u306e\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u304b\u3089\u306e\u8981\u70b9\u3067\u3059\u3002<\/p>","protected":false},"author":1,"featured_media":4487,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"episode_type":"","audio_file":"","podmotor_file_id":"","podmotor_episode_id":"","cover_image":"","cover_image_id":"","duration":"","filesize":"","filesize_raw":"","date_recorded":"","explicit":"","block":"","itunes_episode_number":"","itunes_title":"","itunes_season_number":"","itunes_episode_type":"","footnotes":""},"categories":[209,8],"tags":[106,348,346,350,349,45,351,347],"series":[],"class_list":["post-4486","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-conversation-with","category-leadership","tag-conversation-with","tag-decision-making","tag-healthcare","tag-kasper-bodker-mejlvang","tag-nemawashi","tag-obesity","tag-pharmaceuticals","tag-regulations-in-japan"],"episode_featured_image":"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2024\/09\/KasperBodkerMejlvang-1.jpg","episode_player_image":"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2026\/04\/Podcast-Cover-copy-scaled.jpg","download_link":"","player_link":"","audio_player":false,"episode_data":{"playerMode":"dark","subscribeUrls":{"apple_podcasts":{"key":"apple_podcasts","url":"","label":"Apple Podcasts","class":"apple_podcasts","icon":"apple-podcasts.png"},"stitcher":{"key":"stitcher","url":"","label":"Stitcher","class":"stitcher","icon":"stitcher.png"},"google_podcasts":{"key":"google_podcasts","url":"","label":"Google Podcasts","class":"google_podcasts","icon":"google-podcasts.png"},"spotify":{"key":"spotify","url":"","label":"Spotify","class":"spotify","icon":"spotify.png"}},"rssFeedUrl":"https:\/\/stevenbleistein.net\/ja\/feed\/podcast\/the-growth-zone","embedCode":"<blockquote class=\"wp-embedded-content\" data-secret=\"hXVc0fCW2B\"><a href=\"https:\/\/stevenbleistein.net\/ja\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/\">Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/stevenbleistein.net\/ja\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/embed\/#?secret=hXVc0fCW2B\" width=\"500\" height=\"350\" title=\"&#8220;Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang&#8221; &#8212; Steven Bleistein\" data-secret=\"hXVc0fCW2B\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/stevenbleistein.net\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang - Steven Bleistein<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stevenbleistein.net\/ja\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang - Steven Bleistein\" \/>\n<meta property=\"og:description\" content=\"On September 25th, I conducted an onstage conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang at the French Chamber of Commerce in Japan. Below are my takeaways from the discussion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stevenbleistein.net\/ja\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/\" \/>\n<meta property=\"og:site_name\" content=\"Steven Bleistein\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-26T19:30:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-27T23:43:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2024\/09\/KasperBodkerMejlvang-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"650\" \/>\n\t<meta property=\"og:image:height\" content=\"420\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cd20sbrelansa22\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"cd20sbrelansa22\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/\"},\"author\":{\"name\":\"cd20sbrelansa22\",\"@id\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/#\\\/schema\\\/person\\\/5ddbbb24d1b1ec4851e36e3051da6ee3\"},\"headline\":\"Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang\",\"datePublished\":\"2024-09-26T19:30:28+00:00\",\"dateModified\":\"2024-09-27T23:43:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/\"},\"wordCount\":339,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stevenbleistein.net\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/KasperBodkerMejlvang-1.jpg\",\"keywords\":[\"conversation with\",\"decision-making\",\"healthcare\",\"Kasper B\u00f8dker Mejlvang\",\"nemawashi\",\"obesity\",\"pharmaceuticals\",\"regulations in Japan\"],\"articleSection\":[\"Conversation with\",\"Leadership\"],\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/\",\"url\":\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/\",\"name\":\"Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang - Steven Bleistein\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stevenbleistein.net\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/KasperBodkerMejlvang-1.jpg\",\"datePublished\":\"2024-09-26T19:30:28+00:00\",\"dateModified\":\"2024-09-27T23:43:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stevenbleistein.net\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/KasperBodkerMejlvang-1.jpg\",\"contentUrl\":\"https:\\\/\\\/stevenbleistein.net\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/KasperBodkerMejlvang-1.jpg\",\"width\":650,\"height\":420,\"caption\":\"Kasper Bodker Mejivang\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stevenbleistein.net\\\/2024\\\/09\\\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stevenbleistein.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/#website\",\"url\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/\",\"name\":\"Steven Bleistein\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/#organization\",\"name\":\"Steven Bleistein\",\"url\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stevenbleistein.net\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/steven-bleistein-expert-dramtic-business-growth-logo-02.png\",\"contentUrl\":\"https:\\\/\\\/stevenbleistein.net\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/steven-bleistein-expert-dramtic-business-growth-logo-02.png\",\"width\":1000,\"height\":535,\"caption\":\"Steven Bleistein\"},\"image\":{\"@id\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mxl.68d.myftpupload.com\\\/#\\\/schema\\\/person\\\/5ddbbb24d1b1ec4851e36e3051da6ee3\",\"name\":\"cd20sbrelansa22\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0073cefd6a8cbb324d9e85a5bed7b944e87d002ebf14a49890962955d9298e96?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0073cefd6a8cbb324d9e85a5bed7b944e87d002ebf14a49890962955d9298e96?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0073cefd6a8cbb324d9e85a5bed7b944e87d002ebf14a49890962955d9298e96?s=96&d=mm&r=g\",\"caption\":\"cd20sbrelansa22\"},\"sameAs\":[\"https:\\\/\\\/stevenbleistein.net\"],\"url\":\"https:\\\/\\\/stevenbleistein.net\\\/ja\\\/author\\\/cd20sbrelansa22\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang - Steven Bleistein","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stevenbleistein.net\/ja\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/","og_locale":"ja_JP","og_type":"article","og_title":"Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang - Steven Bleistein","og_description":"On September 25th, I conducted an onstage conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang at the French Chamber of Commerce in Japan. Below are my takeaways from the discussion.","og_url":"https:\/\/stevenbleistein.net\/ja\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/","og_site_name":"Steven Bleistein","article_published_time":"2024-09-26T19:30:28+00:00","article_modified_time":"2024-09-27T23:43:08+00:00","og_image":[{"width":650,"height":420,"url":"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2024\/09\/KasperBodkerMejlvang-1.jpg","type":"image\/jpeg"}],"author":"cd20sbrelansa22","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"cd20sbrelansa22","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/#article","isPartOf":{"@id":"https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/"},"author":{"name":"cd20sbrelansa22","@id":"https:\/\/mxl.68d.myftpupload.com\/#\/schema\/person\/5ddbbb24d1b1ec4851e36e3051da6ee3"},"headline":"Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang","datePublished":"2024-09-26T19:30:28+00:00","dateModified":"2024-09-27T23:43:08+00:00","mainEntityOfPage":{"@id":"https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/"},"wordCount":339,"commentCount":0,"publisher":{"@id":"https:\/\/mxl.68d.myftpupload.com\/#organization"},"image":{"@id":"https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/#primaryimage"},"thumbnailUrl":"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2024\/09\/KasperBodkerMejlvang-1.jpg","keywords":["conversation with","decision-making","healthcare","Kasper B\u00f8dker Mejlvang","nemawashi","obesity","pharmaceuticals","regulations in Japan"],"articleSection":["Conversation with","Leadership"],"inLanguage":"ja","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/","url":"https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/","name":"Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang - Steven Bleistein","isPartOf":{"@id":"https:\/\/mxl.68d.myftpupload.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/#primaryimage"},"image":{"@id":"https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/#primaryimage"},"thumbnailUrl":"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2024\/09\/KasperBodkerMejlvang-1.jpg","datePublished":"2024-09-26T19:30:28+00:00","dateModified":"2024-09-27T23:43:08+00:00","breadcrumb":{"@id":"https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/#primaryimage","url":"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2024\/09\/KasperBodkerMejlvang-1.jpg","contentUrl":"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2024\/09\/KasperBodkerMejlvang-1.jpg","width":650,"height":420,"caption":"Kasper Bodker Mejivang"},{"@type":"BreadcrumbList","@id":"https:\/\/stevenbleistein.net\/2024\/09\/takeaways-conversation-with-novo-nordisk-pharma-japan-president-and-representative-director-kasper-bodker-mejlvang\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stevenbleistein.net\/"},{"@type":"ListItem","position":2,"name":"Takeaways: Conversation with Novo Nordisk Pharma Japan President and Representative Director Kasper B\u00f8dker Mejlvang"}]},{"@type":"WebSite","@id":"https:\/\/mxl.68d.myftpupload.com\/#website","url":"https:\/\/mxl.68d.myftpupload.com\/","name":"Steven Bleistein","description":"","publisher":{"@id":"https:\/\/mxl.68d.myftpupload.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mxl.68d.myftpupload.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/mxl.68d.myftpupload.com\/#organization","name":"Steven Bleistein","url":"https:\/\/mxl.68d.myftpupload.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/mxl.68d.myftpupload.com\/#\/schema\/logo\/image\/","url":"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2022\/12\/steven-bleistein-expert-dramtic-business-growth-logo-02.png","contentUrl":"https:\/\/stevenbleistein.net\/wp-content\/uploads\/2022\/12\/steven-bleistein-expert-dramtic-business-growth-logo-02.png","width":1000,"height":535,"caption":"Steven Bleistein"},"image":{"@id":"https:\/\/mxl.68d.myftpupload.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/mxl.68d.myftpupload.com\/#\/schema\/person\/5ddbbb24d1b1ec4851e36e3051da6ee3","name":"cd20sbrelansa22","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/secure.gravatar.com\/avatar\/0073cefd6a8cbb324d9e85a5bed7b944e87d002ebf14a49890962955d9298e96?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0073cefd6a8cbb324d9e85a5bed7b944e87d002ebf14a49890962955d9298e96?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0073cefd6a8cbb324d9e85a5bed7b944e87d002ebf14a49890962955d9298e96?s=96&d=mm&r=g","caption":"cd20sbrelansa22"},"sameAs":["https:\/\/stevenbleistein.net"],"url":"https:\/\/stevenbleistein.net\/ja\/author\/cd20sbrelansa22\/"}]}},"_links":{"self":[{"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/posts\/4486","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/comments?post=4486"}],"version-history":[{"count":1,"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/posts\/4486\/revisions"}],"predecessor-version":[{"id":4489,"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/posts\/4486\/revisions\/4489"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/media\/4487"}],"wp:attachment":[{"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/media?parent=4486"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/categories?post=4486"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/tags?post=4486"},{"taxonomy":"series","embeddable":true,"href":"https:\/\/stevenbleistein.net\/ja\/wp-json\/wp\/v2\/series?post=4486"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}